Recombinant Human IL-17E (Human Cell-expressed) Protein

R&D Systems, part of Bio-Techne | Catalog # 8134-IL

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Carrier Free
8134-IL-025/CF
Catalog #
Availability
Size / Price
Qty
With Carrier
8134-IL-010
8134-IL-025
Show More Sizes
8134-IL-100
Show Fewer Sizes
Print Quote
Bulk Order
100% Guarantee

Key Product Details

  • R&D Systems HEK293-derived Recombinant Human IL-17E (Human Cell-expressed) Protein (8134-IL)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

HEK293

Accession #

Q9H293

Structure / Form

Disulfide-linked homodimer

Conjugate

Unconjugated

Applications

Bioactivity

View all IL-17E/IL-25 Proteins and Enzymes »

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human IL-17E/IL-25 protein
Tyr33-Gly177

Purity

>95%, by SDS-PAGE with silver staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Tyr33

Predicted Molecular Mass

17 kDa (monomer)

SDS-PAGE

20-28 kDa, reducing conditions

Activity

Measured by its ability to induce CXCL1/GRO alpha secretion in HT-29 human colon adenocarcinoma cells.
The ED50 for this effect is 0.25-1.5 ng/mL.

Reviewed Applications

Read 1 review rated 5 using 8134-IL in the following applications:

Scientific Data Images for Recombinant Human IL-17E (Human Cell-expressed) Protein

IL-17E Induces CXCL1/GRO alpha Secretion.

IL-17E Induces CXCL1/GRO alpha Secretion.

Recombinant Human IL-17E/IL-25 (Catalog # 8134-IL) induces CXCL1/GRO alpha secretion in HT‑29 human colon adenocarcinoma cells. The ED50 for this effect is 0.25-1.5 ng/mL.
IL-17E Induces CXCL1/GRO alpha Secretion.

IL-17E Induces CXCL1/GRO alpha Secretion.

1 μg/lane of Recombinant Human IL-17E (Catalog # 8134-IL) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by silver staining, showing R bands at 20-28 kDa and NR bands at 37-43 kDa.

Formulation, Preparation and Storage

Carrier Free
What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Carrier: 8134-IL
Formulation Lyophilized from a 0.2 μm filtered solution in HCl with BSA as a carrier protein.
Reconstitution Reconstitute at 100 μg/mL in 4 mM HCl containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Carrier Free: 8134-IL/CF
Formulation Lyophilized from a 0.2 μm filtered solution in HCl.
Reconstitution Reconstitute at 100 μg/mL in 4 mM HCl.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: IL-17E/IL-25

The Interleukin-17 (IL-17) family of proteins are immunoregulatory cytokines that share a conserved cysteine-rich region. IL-17E, which is also known as IL-25, promotes Th2-biased immune responses. This is in contrast to other IL-17 family members which promote Th1- and Th17-biased inflammation. IL-25 is an important mediator of allergic reactions and protection against intestinal parasites (1, 2). Mature human IL-25 shares 80% amino acid sequence identity with mouse and rat IL-25 (3, 4). During helminth infections and allergic reactions, IL-25 is locally up-regulated in intestinal and airway epithelial cells, atopic dermatitis skin lesions, and local Th2 cells, eosinophils, and basophils (4-9). It binds to IL-17 RB but also requires IL-17 RA to exert its activity (3, 8, 10). IL-25 acts on a variety of cell types which respond with increased production of Th2 cytokines (e.g. IL-4, IL-5, IL-13) and reduced production of Th1 and Th17 cytokines (e.g. IFN-gamma, IL-12, IL-23, IL-17A, IL-17F) (4-6, 8, 9, 11-15). Airway IL-25 can be activated by MMP-7, a protease that is up-regulated in airway epithelium in response to allergen exposure (16). Cleaved IL-25 shows enhanced binding to IL-17 RB and stronger induction of Th2 cytokines (16). The Th2 cytokines, in turn, trigger expansion of Th2 memory cells and
anti‑inflammatory M2 macrophages, increased eosinophil mobilization and activation, and dendritic cell migration (4, 6, 9, 13). These actions promote protective
anti‑helminth immune responses (4, 5) as well as allergic inflammation and airway hyperreactivity (11). The IL-25 induced suppression of Th1 and Th17 cytokines limits Th17 cell expansion and disease pathology in autoimmunity and colitis [12, 15]. IL-25 also promotes vascular endothelial cell proliferation and assembly into tubular structures (7). It supports the integrity of the blood-brain barrier and limits CD4+ T cell infiltration into the brain (17).

References

  1. Saadoun, D. et al. (2011) Curr. Pharm. Des. 17:3781.
  2. Iwakura, Y. et al. (2011) Immunity 34:149.
  3. Lee, J. et al. (2001) J. Biol. Chem. 276:1660.
  4. Fort, M.M. et al. (2001) Immunity 15:985.
  5. Zhao, A. et al. (2010) J. Immunol. 185:6921.
  6. Suzukawa, M. et al. (2012) J. Immunol. 189:3641.
  7. Corrigan, C.J. et al. (2011) Proc. Natl. Acad. Sci. USA 108:1579.
  8. Petersen, B.C. et al. (2012) Nat. Med. 18:751.
  9. Wang, Y.-H. et al. (2007) J. Exp. Med. 204:1837.
  10. Rickel, E.A. et al. (2008) J. Immunol. 181:4299.
  11. Hurst, S.D. et al. (2002) J. Immunol. 169:443.
  12. Kleinschek, M.A. et al. (2007) J. Exp. Med. 204:161.
  13. Cao, Q. et al. (2011) J. Am. Soc. Nephrol. 22:1229.
  14. Stock, P. et al. (2009) J. Immunol. 182:5116.
  15. Caruso, R. et al. (2009) Gastroenterology 136:2270.
  16. Goswami, S. et al. (2009) Nat. Immunol. 10:496.
  17. Sonobe, Y. et al. (2009) J. Biol. Chem. 284:31834.

Long Name

Interleukin 17E

Alternate Names

IL-25, IL17E, IL25

Entrez Gene IDs

64806 (Human); 140806 (Mouse); 501996 (Rat)

Gene Symbol

IL25

UniProt

Q9H293

Additional IL-17E/IL-25 Products

Product Documents for Recombinant Human IL-17E (Human Cell-expressed) Protein

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS 8134-IL (with carrier)
Download SDS 8134-IL/CF (carrier free)

Product Specific Notices for Recombinant Human IL-17E (Human Cell-expressed) Protein

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2026 Bio-Techne. All Rights Reserved. All trademarks and registered trademarks are the property of Bio-Techne and its brands unless otherwise specified.